Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05c7 trial

Amanda R. Moraska, Amit Sood, Shaker R. Dakhil, Jeff A. Sloan, Debra Barton, Pamela J. Atherton, Jason J. Suh, Patricia C. Griffin, David B. Johnson, Aneela Ali, Peter T. Silberstein, Steven F. Duane, Charles L. Loprinzi

Research output: Contribution to journalArticlepeer-review

126 Scopus citations

Fingerprint

Dive into the research topics of 'Phase III, randomized, double-blind, placebo-controlled study of long-acting methylphenidate for cancer-related fatigue: North Central Cancer Treatment Group NCCTG-N05c7 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences